客户端 果下科技今日正式登陆港交所主板，首日表现强劲。该股开盘报38港元，较发行价20.10港元大幅高开 89.05%，成交额达1.32亿港元。不计手续费，每手100股可赚1790港元。 | 02655 果下科技 | | | | --- | --- | --- | | 38.0001+17.900 +89.05% | | 等待开盘 12/16 09:20 | | * 72 日 = | | ● 快捷交易 | | 最高价 38.000 | 开盘价 38.000 | 成交量 370.86万 | | 曼低价 38.000 | 昨收价 20.100 | 成交额 1.32亿 | | 平均价 35.687 | | 市盈率TTM 218.39 总市值 192.58亿 (m) | | 振 幅 -- | 市盈率(静) 358.49 | 总股本 5.07亿 | | 换手率 0.97% | 市净率 58.641 | 流通值 145.83亿 | | 52周景高 38,000 | 委 比 -20.00% | 流通股 3.84亿 | | 52周最低 38.000 | 量 比 -- | 每 手 100股 | | 历史最高 38.000 | ...

此次公司香港公开发售获1890.73倍认购，国际发售获3.63倍认购。 果下科技公布全球发售配发结果。公司全球发售约3893.08万股H股，其中香港公开发售占8.7%，国际 发售占91.3%。发售价定为每股20.1港元，每手买卖单位为100股H股，H股将于2025年12月16日(星期二) 上午九时开始在联交所买卖。 ...

Group 1: Medical Isotope Production - China National Nuclear Corporation (CNNC) has successfully developed a complete technology chain for the irradiation preparation of iodine-131, enhancing the self-sufficiency of medical isotopes in China [1] - The technology includes the preparation of precursor isotopes, reactor irradiation, and nuclear drug development, forming an environmentally friendly and autonomous industrial chain [1] - The successful production of high-purity tellurium-130 isotopes with over 99% abundance fills a gap in the domestic large-scale preparation of high-purity enriched tellurium isotopes [1] Group 2: Radiation Therapy Equipment and Drug Development - As of 2024, over 90 radiotherapy devices have been approved by the National Medical Products Administration, with more than 70% being domestic brands, significantly reducing reliance on imported equipment [2] - The development of new radiopharmaceuticals has accelerated, with over 200 pipelines entering clinical trials, introducing new isotopes like lutetium-177 and yttrium-90 for more precise cancer treatment options [2] Group 3: Corporate Transactions and Financial Updates - WuXi AppTec has completed the sale of its subsidiary, expecting a post-tax net profit of approximately 960 million yuan, which accounts for over 10% of the company's latest audited net profit attributable to shareholders [5][6] - Guolian Minsheng has terminated a 480 million yuan fund establishment transaction, with no adverse effects on the company's finances or shareholder rights [7] - Morning Paper Industry plans to sell all shares of a target company for 3.336 billion yuan [10] Group 4: New Technologies and Innovations - GAC Group's flying car, GOVY AirCab, has entered the airworthiness certification stage and is expected to be mass-produced by 2026, aiming to create a new mode of transportation that integrates air and ground travel [17] - China Tongyuan has signed a commercial cooperation agreement with Novartis for the radiopharmaceutical product, providing a new treatment option for advanced prostate cancer patients [18]

今日果下科技(2655.HK)上市，翰思艾泰-B(3378.HK)、轻松健康(2661.HK)、诺比侃(2635.HK)、华芢生 物-B(2396.HK)、明基医院(2581.HK)、南华期货股份(2691.HK)、印象大红袍(2695.HK)、智汇矿业 (2546.HK)、希迪智驾(3881.HK)申购。 本文源自：金融界AI电报 ...

New IPOs - Guoxia Technology (02655) received a subscription rate of 1890.73 times for its public offering in Hong Kong, with a share price of HKD 20.1 [1] - Easy Health (02661), Hansai Aitai-B (03378), and Nobi Kan (02635) are scheduled for public offerings from December 15 to December 18, with expected listing on December 23 [1] Major Events - Luoyang Molybdenum (03993) plans to acquire three major gold mining assets in Brazil for USD 1.015 billion [1] - Zhongwei New Materials (02579) has been included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect securities list [1] - Botai Carlink (02889) received a first project confirmation notice from a leading domestic new energy vehicle client [1] - Xiehe New Energy (00182) intends to sell 100% equity of Cangzhou Julong for CNY 65.3 million [1] - Fosun Pharma (02196) plans to invest a total of CNY 1.412 billion to gain control of Green Valley Pharmaceutical [1] - Youqu Holdings (02177) intends to spend JPY 2.701 billion to acquire the Japanese consulting pharmacy chain Akahige [1] Financial Data - China Metallurgical Group (01618) signed new contracts worth CNY 958.13 billion in the first 11 months, a decrease of 8.6% year-on-year [1] - Xinhua Insurance (01336) reported a cumulative original insurance premium income of CNY 188.85 billion in the first 11 months, an increase of 16% year-on-year [1] - China Southern Airlines (01055) saw a 10.42% year-on-year increase in passenger turnover in November [1] - China Shenhua (01088) reported coal sales of 389.5 million tons in the first 11 months, a decrease of 7.7% year-on-year [1] - China Eastern Airlines (00670) experienced a 10.35% year-on-year increase in passenger turnover in November [1] - Air China (00753) reported a 10.1% year-on-year increase in passenger turnover in November [1] Share Buybacks - Tencent Holdings (00700) repurchased 1.051 million shares for HKD 636 million on December 15 [2] - Xiaomi Group-W (01810) repurchased 7.2 million shares for HKD 302 million on December 15 [2] - Geely Automobile (00175) repurchased 1.991 million shares for HKD 34.7485 million on December 15 [2] - Kuaishou-W (01024) repurchased 462,000 shares for HKD 29.9304 million on December 15 [2] - Rongchang Bio (09995) plans to repurchase shares worth between CNY 2 million and CNY 4 million [2] - Gendyn New Drug (01952) received over HKD 38 million in share purchases from directors and major shareholders [2]

其中，香港公开发售获1890.73倍认购，国际发售获3.63倍认购。 果下科技(02655)公布配发结果，公司全球发售约3893.08股H股，香港公开发售占8.7%，国际发售占 91.3%。每股发售价20.1港元，全球发售净筹7.01亿港元。每手100股H股，预期H股将于2025年12月16 日(星期二)上午九时正开始在联交所买卖。 ...

格隆汇12月15日丨果下科技(02655.HK)公告，公司全球发售38,930,800股H股，每股H股20.1港元，所得 款项净额7亿港元。香港公开发售股份数目占全球发售股份数目8.70%，获认购1890.73倍；国际发售股 份数目占全球发售股份91.30%，获认购倍3.63倍。 假设全球发售于2025年12月16日(星期二)上午八时正(香港时间)或之前成为无条件，预期H股将于2025 年12月16日(星期二)上午九时正在联交所开始买卖。H股的每手买卖单位为100股H股，H股的股份代号 为2655。 ...

智通财经APP讯，果下科技(02655)公布配发结果，公司全球发售约3893.08股H股，香港公开发售占 8.7%，国际发售占91.3%。每股发售价20.1港元，全球发售净筹7.01亿港元。每手100股H股，预期H股 将于2025年12月16日(星期二)上午九时正开始在联交所买卖。 其中，香港公开发售获1890.73倍认购，国际发售获3.63倍认购。 ...

除 非 本 公 告 另 有 界 定，否 則 本 公 告 所 用 詞 彙 與 招 股 章 程 所 界 定 者 具 有 相 同 涵 義。 – 1 – 香 港 交 易 及 結 算 所 有 限 公 司、香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）及 香 港 中 央 結 算 有 限 公 司（「香港結算」）對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或 任 何 部 分 內 容 而 產 生 或 因 依 賴 該 等 內 容 引 致 的 任 何 損 失 承 擔 任 何 責 任。 本 公 告 不 會 直 接 或 間 接 在 或 向 美 國（包 括 其 領 土 及 屬 地、美 國 任 何 州 以 及 哥 倫 比 亞 特 區）發 佈、刊 發 或 派 發。本 公 告 並 非 亦 無 意 構 成 或 組 成 於 美 國 或 任 何 其 他 司 法 管 轄 區 購 買 或 認 購 證 券 的 任 何 要 約 或 招 攬 的 一 部 分。發 售股份不曾亦不會根據1933年 美 國 證 券 法（經 不 時 修 ...

Core Viewpoint - Guokai Technology (02655), a leader in AI internet energy storage and the first stock in AI robotics safety, is set to be listed on the Hong Kong Stock Exchange on December 16, 2025, with a significant increase in its share price during pre-listing trading [1] Group 1: Company Overview - Guokai Technology's shares were quoted at HKD 37.80 in dark pool trading, representing an 88.06% increase from the offering price of HKD 20.10 [1] - Each lot consists of 100 shares, resulting in a potential profit of HKD 1,770 per lot, excluding fees [1] Group 2: Market Demand - The public offering of Guokai Technology recorded over 1,800 times oversubscription, with total subscription amounts exceeding HKD 130 billion, making it the most oversubscribed IPO in the AI robotics safety sector this year [1] - Notable long-term funds such as VanCapital, Schonfeld, Symmetry, and InfiniCapital actively participated in the offering [1]